ArticleScience advances2020
Mapping of host-parasite-microbiome interactions reveals metabolic determinants of tropism and tolerance in Chagas disease.
Abstract read
In one paragraph
Article in Science advances, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.
0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
48 citing papers in PubMed.
- Article
- Mass spectrometry-based metabolomics approaches to interrogate host-microbiome interactions in mammalian systems.Natural product reports · 2026Review
- Exploring Acylcarnitine Metabolism Using Reverse Metabolomics.Analytical chemistry · 2026Article
- Small is big: growing impact of small molecule mass spectrometry in infectious disease drug development.mSphere · 2026Review
- Desorption Electrospray Ionization-Mass Spectrometry Imaging (DESI-MSI) of Metabolites in Heart Samples Infected with Trypanosoma cruzi.Methods in molecular biology (Clifton, N.J.) · 2026Article
- Microbiome Profiling in Chagas Disease: Sample Collection, Sequencing, and Analysis.Methods in molecular biology (Clifton, N.J.) · 2026Article
- Spatially divergent metabolic impact of experimental toxoplasmosis: immunological and microbial correlates.mSystems · 2025Article
- Coinfection by multipleMicrobiology and molecular biology reviews : MMBR · 2025Review
- Biological and Molecular Characterization of FiveTropical medicine and infectious disease · 2025Article
- Article
- System-based insights into parasitological and clinical treatment failure in Chagas disease.mSystems · 2025Review
- Parasite-microbiota interactions: a pathway to innovative interventions for Chagas disease, leishmaniasis, and ascariasis.Future microbiology · 2025Review
- Animal models for exploring Chagas disease pathogenesis and supporting drug discovery.Clinical microbiology reviews · 2024Review
- Network Analysis of Pathogenesis Markers in Murine Chagas Disease Under Antimicrobial Treatment.Microorganisms · 2024Article
- Nicotinamide mitigates visceral leishmaniasis by regulating inflammatory response and enhancing lipid metabolism.Parasites & vectors · 2024Article
- Pirfenidone Prevents Heart Fibrosis during Chronic Chagas Disease Cardiomyopathy.International journal of molecular sciences · 2024Article
- Frontiers in Mass Spectrometry-Based Spatial Metabolomics: Current Applications and Challenges in the Context of Biomedical Research.Trends in analytical chemistry : TRAC · 2024Article
- Rationally Minimizing Natural Product Libraries Using Mass Spectrometry.bioRxiv : the preprint server for biology · 2024Article
- Enteric nervous system regeneration and functional cure of experimental digestive Chagas disease with trypanocidal chemotherapy.Nature communications · 2024Article
- The End Justifies the Means: Chagas Disease from a Perspective of the Host-Life (Basel, Switzerland) · 2024Review
Corrections and comments
- Commented on by
Authors and funding
17 authors.
E HossainDepartment of Chemistry and Biochemistry, University of Oklahoma, Norman, OK 73019, USA.ORCID 0000-0002-0616-3420
S KhanamLaboratories of Molecular Anthropology and Microbiome Research, University of Oklahoma, Norman, OK 73019, USA.ORCID 0000-0001-8451-6175
D A DeanDepartment of Chemistry and Biochemistry, University of Oklahoma, Norman, OK 73019, USA.ORCID 0000-0001-6830-4957
C WuDepartment of Chemistry and Biochemistry, University of Oklahoma, Norman, OK 73019, USA.
S Lostracco-JohnsonSkaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, CA 92093, USA.
D ThomasSkaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, CA 92093, USA.
S S KaneDepartment of Chemistry and Biochemistry, University of Oklahoma, Norman, OK 73019, USA.ORCID 0000-0002-4604-5381
A R ParabLaboratories of Molecular Anthropology and Microbiome Research, University of Oklahoma, Norman, OK 73019, USA.
K FloresLaboratories of Molecular Anthropology and Microbiome Research, University of Oklahoma, Norman, OK 73019, USA.
M KatemauswaDepartment of Chemistry and Biochemistry, University of Oklahoma, Norman, OK 73019, USA.ORCID 0000-0001-9624-8737
C GosmanovDepartment of Chemistry and Biochemistry, University of Oklahoma, Norman, OK 73019, USA.
S E HayesDepartment of Chemistry and Biochemistry, University of Oklahoma, Norman, OK 73019, USA.
Y ZhangDepartment of Chemistry and Biochemistry, University of Oklahoma, Norman, OK 73019, USA.
D LiCollege of Chemistry, Beijing Normal University, Beijing 100875, China.ORCID 0000-0002-8572-5128
C Woelfel-MonsivaisLaboratories of Molecular Anthropology and Microbiome Research, University of Oklahoma, Norman, OK 73019, USA.ORCID 0000-0001-6465-5573
K SankaranarayananLaboratories of Molecular Anthropology and Microbiome Research, University of Oklahoma, Norman, OK 73019, USA.ORCID 0000-0002-4767-311X
L-I McCallDepartment of Chemistry and Biochemistry, University of Oklahoma, Norman, OK 73019, USA.ORCID 0000-0002-1243-8953
Funding
Tissue Pathology Shared ResourceP30CA225520 · NCI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Wade Williams · 2018 to 2026
$27.1MTUMOR RESISTANCE MECHANISMS TO ANTI-VEGF THERAPY IN PROSTATE CANCER (Sukyung Woo)P20GM103639 · NIGMS · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI DHANASEKARAN, DANNY N. · 2012 to 2022
$21.3MStructure-Function Studies of MsvR, a Methanogen-Specific Transcriptional RegulaP20GM103640 · NIGMS · UNIVERSITY OF OKLAHOMA · PI THOMAS, LEONARD M · 2012 to 2021
$20.4MMicrobial Ecologies of Indigenous CommunitiesR01GM089886 · NIGMS · UNIVERSITY OF OKLAHOMA · PI LAWSON, PAUL ALAN, LEWIS, CECIL M · 2011 to 2019
$2.4MOral carnitine administration as a novel treatment for chronic-stage Chagas diseaseR21AI148886 · NIAID · UNIVERSITY OF OKLAHOMA · PI MCCALL, LAURA-ISOBEL · 2020 to 2021
$426kNCI NIH HHS P30 CA225520NIAID NIH HHS R21 AI148886NIGMS NIH HHS P20 GM103639NIGMS NIH HHS P20 GM103640NIGMS NIH HHS R01 GM089886
Abstract
Chagas disease (CD) is a parasitic disease caused by
Indexed as
Chagas DiseaseMicrobiotaParasitesTrypanosoma cruziAnimalsMiceTropism
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.